Skip to main content

Table 4 HPV genotype distribution in coinfection cases

From: Human papillomavirus genotypes in human immunodeficiency virus-positive patients with anal pathology in Madrid, Spain

Genotype found

LASIL

HASIL

 

N

% *

CI95%

% **

CI95%

N

% *

CI95%

% **

CI95%

HR-HPVs

          

16

12

9.0

4.7-15.2

37.5

21.1-56.3

10

12.8

6.3-22.3

52.6

28.9-75.6

18

0

0.0

0.0-2.7

0.0

0.0-10.9

2

2.6

0.3-9.0

10.5

1.3-33.1

31

6

4.5

1.7-9.6

18.8

7.2-36.4

6

7.7

2.9-16.0

31.6

12.6-56.6

33

2

1.5

0.2-5.3

6.3

0.8-20.8

4

5.1

1.4-12.6

21.1

6.1-45.6

35

3

2.3

0.5-6.5

9.4

2.0-25.0

2

2.6

0.3-9.0

10.5

1.3-33.1

39

3

2.3

0.5-6.5

9.4

2.0-25.0

1

1.3

0.0-6.9

5.3

0.1-26.0

45

6

4.5

1.7-9.6

18.8

7.2-36.4

2

2.6

0.3-9.0

10.5

1.3-33.1

51

10

7.5

3.7-13.4

31.3

16.1-50.0

4

5.1

1.4-12.6

21.1

6.1-45.6

52

10

7.5

3.7-13.4

31.3

16.1-50.0

6

7.7

2.9-16.0

31.6

12.6-56.6

56

4

3.0

0.8-7.5

12.5

3.5-29.0

1

1.3

0.0-6.9

5.3

0.1-26.0

58

6

4.5

1.7-9.6

18.8

7.2-36.4

7

9.0

3.7-17.6

36.8

16.3-61.6

59

3

2.3

0.5-6.5

9.4

2.0-25.0

4

5.1

1.4-12.6

21.1

6.1-45.6

73

4

3.0

0.8-7.5

12.5

3.5-29.0

1

1.3

0.0-6.9

5.3

0.1-26.0

81

3

2.3

0.5-6.5

9.4

2.0-25.0

1

1.3

0.0-6.9

5.3

0.1-26.0

82

0

0.0

0.0-2.7

0.0

0.0-10.9

1

1.3

0.0-6.9

5.3

0.1-26.0

PHR/HR-HPVs

          

66/68

5

3.8

1.2-8.6

15.6

5.3-32.8

1

1.3

0.0-6.9

5.3

0.1-26.0

PHR-HPVs

          

53

4

3.0

0.8-7.5

12.5

3.5-29.0

2

2.6

0.3-9.0

10.5

1.3-33.1

LR/PHR-HPVs

          

84/26

1

0.8

0.0-4.1

3.1

0.1-16.2

1

1.3

0.0-6.9

5.3

0.1-26.0

LR-HPVs

          

6

8

6.0

2.6-11.5

25.0

11.5-43.4

6

7.7

2.9-16.0

31.6

12.6-56.6

11

9

6.8

3.1-12.5

28.1

13.7-46.7

3

3.8

0.8-10.8

15.8

3.4-39.6

42

3

2.3

0.5-6.5

9.4

2.0-25.0

2

2.6

0.3-9.0

10.5

1.3-33.1

70

5

3.8

1.2-8.6

15.6

5.3-32.8

2

2.6

0.3-9.0

10.5

1.3-33.1

72

4

3.0

0.8-7.5

12.5

3.5-29.0

1

1.3

0.0-6.9

5.3

0.1-26.0

40/61

7

5.3

2.1-10.5

21.9

9.3-40.0

1

1.3

0.0-6.9

5.3

0.1-26.0

43/44

10

7.5

3.7-13.4

31.3

16.1-50.0

6

7.7

2.9-16.0

31.6

12.6-56.6

54/55

4

3.0

0.8-7.5

12.5

3.5-29.0

1

1.3

0.0-6.9

5.3

0.1-26.0

57/71

1

0.8

0.0-4.1

3.1

0.1-16.2

0

0.0

0.0-4.6

0.0

0.0-17.6

X

0

0

0.0-2.7

0.0

0.0-10.9

0

0.0

0.0-4.6

0.0

0.0-17.6

  1. N: total number of times which each genotype was detected.
  2. * Percentages referred to the total number of virus detected in each kind of lesion (133 virus in LASIL and 78 in HASIL lesions).
  3. ** Percentages referred to the number of lesions infected by one or several genotypes (32 LASIL and 19 HASIL lesions). CI95%: 95% confidence intervals used for estimate percentages.